Zynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational streamlining, and a key FDA submission for its next-generation pulse oximeter.
The company appointed industry veteran Steven Dyson as CEO in Q2, a move founder Thomas Sandgaard called “transformational” for the Colorado-based firm.
374Water Inc (NASDAQ:SCWO) announced that its commercial-scale AirSCWO (Air Supercritical Water Oxidation) system is capable of consistently destroying per- and polyfluoroalkyl substances (PFAS) in biosolids to non-detectable levels.
The company’s technology targets PFAS, a class of synthetic chemicals often referred to as “forever chemicals” due to their persistence in the environment.
Millennial Potash Corp (TSX-V:MLP, OTCQB:MLPNF) said on Thursday it had closed a private placement worth C$9.19 million, with proceeds earmarked for exploration and development at its Banio Potash Project in Gabon.
The company issued 5.92 million units priced at C$1.55 each, with each unit consisting of one common share and one-half of a share purchase warrant. Each full warrant is exercisable at C$2.20 for a period of two years.
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF) announced that drilling has commenced at the Kavango West 1X exploration well in Namibia.
The Kavango West 1X exploration well, also referred to as Prospect I, was spud on July 31.
Abacus Global Management (NASDAQ:ABL) has completed its previously announced exchange offer and consent solicitation, resulting in the elimination of all outstanding public and private placement warrants.
The alternative asset manager issued 4.18 million shares of common stock in exchange for the warrants tendered.
C3 Metals Inc (TSX-V:CCCM, OTC:CARCF) announced that it has strengthened its technical team with the appointment of Dr Stephanie Sykora as chief geologist.
Dr Sykora holds a PhD in Geology from the University of Tasmania, Australia, and a BSc with distinction in Earth Sciences from the University of Victoria, Canada. Her doctoral research focused on the Lihir (Ladolam) alkalic epithermal gold deposit in Papua New Guinea.
Atlantic Lithium Ltd (AIM:ALL, OTCQX:ALLIF, ASX:A11), in its quarterly activities report for the ASX, highlighted that in the three months, it advanced discussions with Ghanaian government representatives to secure revised fiscal terms for the Ewoyaa Mining Lease.
New terms would reflect current lithium prices, it noted.
Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) highlighted major progress across its integrated rare earths supply chain strategy in quarterly results released on Thursday, advancing magnet recycling, refining and project development in the United Kingdom, United States, Brazil and Uganda.
The company’s activities were underpinned by a A$3 million capital raise and supported by growing geopolitical urgency to secure ex-China supplies of magnet and heavy rare earths — particularly following China’s April restrictions on exports of key elements such as dysprosium and terbium.
Australian Vanadium Ltd (ASX:AVL, OTCQB:ATVVF) made strong progress across its vertically integrated vanadium supply chain during the June 2025 quarter, advancing engineering, permitting and commercialisation efforts from mining through to battery energy storage systems (BESS). Highlights include nearing completion of Phase 2 of the Optimised Feasibility Study (OFS), advancing electrolyte manufacturing plans, and progressing VSUN Energy’s Project Lumina towards a potential investment decision in Q3 CY2025.
“AVL continues to build momentum across all pillars of our vertically integrated strategy, with significant progress made this quarter in engineering, permitting and downstream commercial readiness. This work continues to support our ambition to become a globally competitive supplier of battery-grade vanadium products and energy storage solutions," CEO Graham Arvidson said.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), the UK biotechnology company specialising in allergy immunotherapies, has published three new studies in the journal Allergy that strengthen the evidence for its investigational grass pollen allergy treatment, Grass MATA MPL.
The papers focus on the treatment's use in combating allergic rhinoconjunctivitis, a condition involving both nasal and eye symptoms triggered by grass pollen.
London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) has passed a key milestone with more than 1,000 specialised Bitcoin mining computers now operating in the United States and Canada, according to an announcement on Thursday.
The company, which holds and mines Bitcoin as part of its core business, said that growing its North American mining fleet is central to its current strategy.
Sovereign Metals Ltd (ASX:SVM, OTC:SVMLF, AIM:SVML) has reported a productive June quarter marked by major technical and strategic progress at its Kasiya Rutile-Graphite Project in Malawi, alongside a boost from changing global graphite dynamics and strong results from its local community programs.
A geotechnical program critical to Kasiya’s Definitive Feasibility Study (DFS) has been completed, while agreements for long-term power supply have advanced in parallel with positive international recognition for the project's graphite and rutile products. The company also highlighted its expanded conservation farming program, which saw crop yields quadruple for participating farmers.
AuMEGA Metals Ltd (ASX:AAM, TSX:AUM, OTCQB:AUMMF) has completed the first phase of its 2025 drilling campaign at the Cape Ray Project in Newfoundland, Canada, as part of its largest and most systematic exploration effort to date across three key gold projects.
The 2,559.7-metre diamond drilling program targeted resource extensions and new anomalies at Cape Ray, with assays due in early to mid-August. It forms part of a broader strategy to unlock value across AuMEGA’s 110-kilometre land package on the gold-rich Cape Ray–Valentine Lake Shear Zone.
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has delivered a strong June 2025 quarter, marked by a 17% increase in annual recurring revenue (ARR) to A$4.8 million and a 24% year-on-year rise in total revenue to A$1.9 million.
The period also saw major contract wins in the United States, United Kingdom, Japan and Australia, further reinforcing archTIS’ presence in key defence markets. Gross margin lifted to 81%, and positive cash flow from operations reached A$1.4 million. The company ended the quarter with A$4.9 million in available funds, bolstered post-period by a A$7.5 million capital raise, bringing pro-forma cash to A$10.24 million.